Study to Define Safety and Effectiveness of Dolutegravir (DTG) Use in Human Immunodeficiency Virus (HIV) Positive Pregnant Women

NCT03564613 · clinicaltrials.gov ↗
RECRUITING
Status
250
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

ViiV Healthcare